Robert D McBane

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Propensity for young reticulated platelet recruitment into arterial thrombi
    Robert D McBane
    Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN, 55905, USA
    J Thromb Thrombolysis 37:148-54. 2014
  2. doi request reprint Platelet recruitment to venous stent thrombi
    Robert D McBane
    Section of Hematology Research, Mayo Clinic, Rochester, MN, 55905, USA
    J Thromb Thrombolysis 36:442-7. 2013
  3. doi request reprint Adrenal haemorrhage due to heparin-induced thrombocytopenia
    Siva Ketha
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, 200 SW First Street, Rochester, MN 55905, USA
    Thromb Haemost 109:669-75. 2013
  4. ncbi request reprint Fechtner syndrome: physiologic analysis of macrothrombocytopenia
    R D McBane
    Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Blood Coagul Fibrinolysis 11:243-7. 2000
  5. doi request reprint Acquired and congenital risk factors associated with cerebral venous sinus thrombosis
    Robert D McBane
    Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Res 126:81-7. 2010
  6. ncbi request reprint Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs
    Robert D McBane
    Department of Internal Medicine and Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 80:181-6. 2005
  7. doi request reprint Periprocedural anticoagulation management of patients with venous thromboembolism
    Robert D McBane
    Gonda Thrombophilia Clinic, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
    Arterioscler Thromb Vasc Biol 30:442-8. 2010
  8. pmc Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)
    Robert D McBane
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 105:17-24. 2010
  9. ncbi request reprint Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin
    Robert D McBane
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Res 116:525-32. 2005
  10. ncbi request reprint Images in vascular medicine. Cross-clamp injury: an unusual cause of intermittent claudication
    Robert D McBane
    Gonda Vascular Center, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Vasc Med 11:173-4. 2006

Collaborators

Detail Information

Publications54

  1. doi request reprint Propensity for young reticulated platelet recruitment into arterial thrombi
    Robert D McBane
    Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN, 55905, USA
    J Thromb Thrombolysis 37:148-54. 2014
    ..This predisposition may be explained by an increased receptor density of integrin β3 in younger platelets. By this mechanism, the atherosclerotic process may enhance the individual propensity for arterial thrombosis. ..
  2. doi request reprint Platelet recruitment to venous stent thrombi
    Robert D McBane
    Section of Hematology Research, Mayo Clinic, Rochester, MN, 55905, USA
    J Thromb Thrombolysis 36:442-7. 2013
    ..Platelet recruitment to venous stent thrombi occurs in part through the integrin α(IIb)β3 receptor. Unlike arterial thrombosis, inhibition of this receptor is insufficient to prevent venous stent thrombosis...
  3. doi request reprint Adrenal haemorrhage due to heparin-induced thrombocytopenia
    Siva Ketha
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, 200 SW First Street, Rochester, MN 55905, USA
    Thromb Haemost 109:669-75. 2013
    ..This syndrome can occur in the apparent absence of heparin exposure, especially following major joint replacement surgery...
  4. ncbi request reprint Fechtner syndrome: physiologic analysis of macrothrombocytopenia
    R D McBane
    Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Blood Coagul Fibrinolysis 11:243-7. 2000
    ..This case illustrates that 'giant' platelets are not universally present in Fechtner syndrome cases, although the platelets are enlarged. Finally, renal pathology other than Alport's nephropathy may be associated with this syndrome...
  5. doi request reprint Acquired and congenital risk factors associated with cerebral venous sinus thrombosis
    Robert D McBane
    Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Res 126:81-7. 2010
    ....
  6. ncbi request reprint Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs
    Robert D McBane
    Department of Internal Medicine and Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 80:181-6. 2005
    ..To determine the accuracy of 2 commercially available point-of-care devices relative to plasma international normalized ratio (INR) values...
  7. doi request reprint Periprocedural anticoagulation management of patients with venous thromboembolism
    Robert D McBane
    Gonda Thrombophilia Clinic, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
    Arterioscler Thromb Vasc Biol 30:442-8. 2010
    ..The incidence of thromboembolism and bleeding related to periprocedural anticoagulation management of such patients is unknown...
  8. pmc Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)
    Robert D McBane
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 105:17-24. 2010
    ..Targeting the factors that led to the downregulation of PAI-1 in older patients with type 2 DM might offer an attractive strategy for reducing cardiovascular risk...
  9. ncbi request reprint Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin
    Robert D McBane
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Res 116:525-32. 2005
    ..This affinity is inversely proportional to the inhibitory constant for the agent (Ki). Thrombin inhibitors, DuP714 (Ki=10(-11)) and argatroban (Ki=10(-8)), were compared to our previous studies with r-hirudin (Ki=10(-13))...
  10. ncbi request reprint Images in vascular medicine. Cross-clamp injury: an unusual cause of intermittent claudication
    Robert D McBane
    Gonda Vascular Center, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Vasc Med 11:173-4. 2006
  11. ncbi request reprint Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs
    Robert D McBane
    Section of Hematology Research, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 28:413-8. 2008
    ..To address this issue, PD0348292, a direct Factor Xa inhibitor, was compared with antiplatelet therapy in a porcine venous stent model...
  12. ncbi request reprint The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury
    R D McBane
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Eduaction and Research, Rochester, Minnesota 55905, USA
    J Thromb Haemost 2:1834-41. 2004
    ..Arterial thrombosis correlates poorly with any single vitamin K-dependent factor but rather appears to be a function of the entire extrinsic coagulation pathway as measured by the PT-INR...
  13. ncbi request reprint The impact of peripheral arterial disease on circulating platelets
    Robert D McBane
    Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Res 113:137-45. 2004
    ..To measure the effect of a defined arterial injury on platelet function, platelet samples were compared before and 30 min after elective angioplasty...
  14. ncbi request reprint Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi
    W E Wysokinski
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    J Thromb Haemost 2:1637-44. 2004
    ..Quantitative immunohistochemistry was undertaken to define the composition of atrial thrombi and to explore morphological differences between atrial appendage thrombi and those that embolize...
  15. doi request reprint Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis
    Krzysztof Karnicki
    Division of Cardiovascular Medicine, Mayo Clinic, 200 First Street, Rochester, MN, 55905, USA
    Thromb Haemost 99:759-66. 2008
    ..In conclusion, PD0348292 inhibited arterial thrombosis comparable to aspirin plus clopidogrel. Perfusion chamber methodology may be useful in predicting in-vivo antithrombotic efficacy...
  16. doi request reprint Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation
    Waldemar E Wysokinski
    Thrombophilia Clinic, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:639-45. 2008
    ....
  17. doi request reprint Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation
    Naser Ammash
    Department of Internal Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 31:2760-6. 2011
    ..Von Willebrand factor (VWF) is associated with thromboembolism in AF. VWF thrombogenic activity is proportional to multimer size, which is regulated by VWF-cleaving protease (ADAMTS13)...
  18. doi request reprint Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
    Paul R Daniels
    Mayo Clinic Thrombophilia Center, Gonda Vascular Center, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
    Thromb Res 124:300-5. 2009
    ....
  19. pmc Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience
    Andrew K Kurklinsky
    Division of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Vasc Interv Radiol 23:1009-15. 2012
    ..To assess retrospectively 30-day, 1-year, and 3-year patency of chronically occluded iliofemoral venous thrombotic lesions treated with stent placement in a case series from a single institution...
  20. pmc Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin
    Robert W Hoel
    Department of Pharmacy Services, Mayo Clinic, Rochester, MN 55905, USA
    Clin J Am Soc Nephrol 4:99-104. 2009
    ..Anemia is thought to reduce the accuracy of POC INR assay results. Whether POC INR testing could be implemented for hemodialysis patients on chronic warfarin, who are often anemic despite hematopoietic therapy, has not been established...
  21. doi request reprint Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients
    Hosam Attaya
    Mayo Clinic Thrombophilia Center, Gonda Vascular Center, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
    J Thromb Thrombolysis 35:100-6. 2013
    ..This finding underscores the often tenuous nature of distal bypass grafts necessitating an aggressive approach to peri-procedural anticoagulation management...
  22. ncbi request reprint Individual propensity for thrombosis: comparison of venous and arterial circulations
    Waldemar Wysokinski
    Section of Hematology Research Mayo Clinic, Rochester, MN 55905, USA
    Thromb Res 122:390-6. 2008
    ..We furthermore sought to determine whether the thrombotic propensity in the venous circulation is associated with similar propensity for arterial thrombosis...
  23. ncbi request reprint Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis
    Bobby Burches
    Section of Hematology Research Mayo Clinic, Rochester, Minnesota 55905, USA
    Thromb Haemost 96:618-22. 2006
    ..These may represent novel cellular targets for the prevention and treatment of venous thrombosis...
  24. ncbi request reprint Factors contributing to individual propensity for arterial thrombosis
    Krzysztof Karnicki
    Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, Minn 55905, USA
    Arterioscler Thromb Vasc Biol 22:1495-9. 2002
    ....
  25. doi request reprint Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation
    Robert D McBane
    Division of Cardiovascular Medicine, Department of Health Sciences Research, Mayo Clinic and Foundation for Education and Research, 200 First Street S W, Rochester, MN 55905, USA
    Thromb Haemost 99:951-5. 2008
    ..Advanced age, atrial enlargement and other co-morbidities may increase the propensity for the formation of larger thrombi which may bypass the carotid orifice merely as a function of size...
  26. doi request reprint Predicting left atrial thrombi in atrial fibrillation
    Waldemar E Wysokinski
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 159:665-71. 2010
    ..Nearly half of strokes in AF are due to noncardioembolic mechanisms for which antiplatelet therapy would be more appropriate. Previous attempts to develop such tools have been limited by including patients without proven cardioembolism...
  27. doi request reprint Clinical characteristics and long-term follow-up of patients with renal vein thrombosis
    Waldemar E Wysokinski
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Am J Kidney Dis 51:224-32. 2008
    ..The rates of recurrent venous thrombosis and survival for patients with these 2 diseases were compared...
  28. doi request reprint Survival and recurrence in patients with splanchnic vein thromboses
    Mallikarjun R Thatipelli
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 8:200-5. 2010
    ..It is therefore unclear whether thromboses of isolated segments represent unique entities. We compared etiologies, recurrence, and survival of patients with thromboses of different splanchnic venous segments...
  29. ncbi request reprint Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series
    Gregory A Nuttall
    Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Anesth Analg 96:344-50, table of contents. 2003
    ..The patients receiving hirudin did well, but they had a large amount of bleeding, required transfusions of multiple allogeneic blood products, and had a frequent rate of reexploration of the mediastinum after CPB...
  30. ncbi request reprint Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease
    Mallik R Thatipelli
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Vasc Surg 46:62-70; discussion 70. 2007
    ..To determine measures prognostic of adverse events, ankle-brachial index (ABI) was compared with dobutamine stress echocardiography (DSE) in patients referred to our vascular center for the evaluation of PAD...
  31. doi request reprint Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers
    Brad S Karon
    Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Am J Clin Pathol 130:88-92. 2008
    ..5 INR units from the reference method. Median bias between CoaguChek S capillary whole blood and laboratory plasma INRs changed over time, demonstrating the need for ongoing quality assurance measures for POC INR programs...
  32. doi request reprint Platelet factor XIII gene expression and embolic propensity in atrial fibrillation
    Izabella Gosk-Bierska
    Mayo Clinic and Foundation for Education and Research, Rochester, Minnesota, USA
    Thromb Haemost 106:75-82. 2011
    ..Variable factor XIII gene expression in thrombi generated during NVAF may in part explain the propensity to embolisation...
  33. ncbi request reprint Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study
    Lourdes Pena de la Vega
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 80:995-1000. 2005
    ..To determine whether some adverse outcomes of hemodialysis could be explained by subclinical heparin-induced thrombocytopenia (HIT)...
  34. pmc The association of active cancer with venous thromboembolism location: a population-based study
    Alfonso J Tafur
    Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:25-30. 2011
    ..To test active cancer for an association with venous thromboembolism (VTE) location...
  35. doi request reprint Dabigatran: a primer for neurosurgeons
    Jennifer E Fugate
    Division of Critical Care Neurology, Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA
    World Neurosurg 79:154-8. 2013
    ..This study sought to present an overview of dabigatran, a new anticoagulant, and to discuss the implications for the perioperative management of patients taking dabigatran...
  36. ncbi request reprint Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival
    Ewa M Wysokinska
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, Minnesota, 55905 USA
    Thromb Haemost 96:126-31. 2006
    ..Therefore general treatment guidelines for lower extremity DVT may be applicable. Poor survival rates in OVT are principally governed by the presence of malignancy...
  37. ncbi request reprint Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen
    Erzsebet Komorowic
    Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Thromb Haemost 87:763-70. 2002
    ..Our data suggest that the media, despite its fibrillar collagen content, evidenced by electron microscopy, is defective for vWf-binding, which may explain its thromboresistant nature at high shear rates...
  38. ncbi request reprint Influence of anatomical location on arterial thrombosis
    Krzysztof Karnicki
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 22:342-7. 2002
    ..Regional differences in arterial hemodynamics may account for substantial differences in thrombosis arising from deep arterial injury...
  39. doi request reprint Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume
    Andrew K Kurklinsky
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Angiology 62:253-6. 2011
    ..To determine the relationship between fibrin D-dimer levels, symptom duration, and thrombus volume, consecutive patients with incident deep venous thrombosis (DVT) were evaluated...
  40. ncbi request reprint The effects of irreversible JPEG compression on an automated algorithm for measuring carotid artery intima-media thickness from ultrasound images
    N J Hangiandreou
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    J Digit Imaging 15:258-60. 2002
    ..This initial study indicates that compression at 10:1 using baseline JPEG should have little effect on IMT measurements made using the current algorithm, and that compression to 20:1 or 30:1 may be feasible...
  41. ncbi request reprint Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition
    K Karnicki
    Division of Cardiology, May Clinic, Rochester, MN 55905, USA
    J Thromb Haemost 2:2162-9. 2004
    ..The efficacy of a direct factor (F)Xa inhibitor, ZK-807834, was compared with indirect inhibition by enoxaparin for inhibition and deaggregation of acute platelet-rich thrombi in a well-characterized porcine carotid injury model...
  42. doi request reprint Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
    Hosam Attaya
    Mayo Clinic Thrombophilia Center, Gonda Vascular Center, Mayo Clinic, Rochester, MN, United States
    Int J Cardiol 168:5311-5. 2013
    ..outpatient low molecular weight heparin (LMWH) "bridging" as periprocedural anticoagulation management for MHV patients...
  43. ncbi request reprint Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudication
    Waldemar E Wysokinski
    Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN, USA
    Vasc Med 9:315-7. 2004
  44. ncbi request reprint Physical and enzymatic perturbation of the architecture of the Tunica media destroys its inherent thromboresistance
    Erzsebet Komorowicz
    Department of Medical Biochemsitry, Semmelweis University, Budapest, Hungary
    Thromb Haemost 88:827-33. 2002
    ..Collagen in the media may be complexed with another vessel wall component shielding the vWf-binding sites. Mechanical or biochemical processes unmask these sites, and increase the thrombogenicity of the vessel wall...
  45. doi request reprint Surgical pathology of hypothenar hammer syndrome with new pathogenetic insights: A 25-year institutional experience with clinical and pathologic review of 67 cases
    Brandon T Larsen
    Divisions of Anatomic Pathology Cardiovascular Diseases Biomedical Statistics and Informatics Department of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, MN
    Am J Surg Pathol 37:1700-8. 2013
    ..Angiography should be interpreted with caution in superficial locations, as a string-of-beads appearance may simply reflect a posttraumatic corkscrew deformity of the ulnar artery...
  46. doi request reprint Brain lesions in cerebral venous sinus thrombosis
    Alexander Y Zubkov
    Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    Stroke 40:1509-11. 2009
    ..Analyze the relationship between the location and extent of sinus thrombosis and presence and severity of brain lesions...
  47. ncbi request reprint Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy
    R C Shields
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 76:260-6. 2001
    ..In small doses, it does not prolong the patient's time to return to therapeutic anticoagulation...
  48. ncbi request reprint Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients
    Michael B Ishitani
    William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
    Am J Transplant 5:1689-93. 2005
    ..These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality...
  49. ncbi request reprint Platelet characteristics associated with coronary artery disease
    R D McBane
    Division of Cardiovascular Medicine, Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, 200 S W First Street, Rochester, MN 55905, USA
    J Thromb Haemost 1:1296-303. 2003
    ..To measure the effect of angioplasty on platelet function, samples obtained before, 30 min after and 24 h after angioplasty were compared...
  50. ncbi request reprint Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival
    I Gosk-Bierska
    Division of Cardiovascular Medicine, Mayo Clinic, 200 S W First St, Rochester, MN 55905, USA
    Neurology 67:814-9. 2006
    ....
  51. ncbi request reprint Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice
    Emoke Posan
    Visiting Scientist from University of Debrecen, Faculty of Medicine, 2nd Department of Medicine, Debrecen, Hungary
    Thromb Haemost 90:483-90. 2003
    ..When clinical suspicion is strong, testing should be supplemented with assays of von Willebrand factor and platelet aggregometry...
  52. doi request reprint Acute venous disease: venous thrombosis and venous trauma
    Mark H Meissner
    Department of Surgery, University of Washington School of Medicine, Seattle 98195, USA
    J Vasc Surg 46:25S-53S. 2007
    ..Venous injuries are similarly under-reported and the true incidence is unknown. Current recommendations include repair of injuries to the major proximal veins. If repair not safe or possible, ligation should be performed...
  53. ncbi request reprint Cardiomyopathy associated with celiac disease
    Nisheeth K Goel
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 80:674-6. 2005
    ..However, with early diagnosis and treatment with a gluten-free diet, cardiomyopathy in patients with celiac disease may be completely reversible...
  54. ncbi request reprint Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000
    P W Eiken
    Mayo Medical School, Division of Anatomic Pathology, Mayo Clinic, Rochester, Minn. 55905, USA
    Mayo Clin Proc 76:1204-12. 2001
    ....